Immune-related AEs (irAEs) affecting the biliary system on treatment with immune-oncology (I-O) agents, such PD-1/PD-L1 mAbs, are considered rare and their management remains unclear.
Immune-mediated cholangitis: is it always nivolumab’s fault? / Gelsomino, Francesco*; Vitale, Giovanni; Ardizzoni, Andrea. - In: CANCER IMMUNOLOGY, IMMUNOTHERAPY. - ISSN 0340-7004. - STAMPA. - 67:8(2018), pp. 1325-1327. [10.1007/s00262-018-2159-3]
Immune-mediated cholangitis: is it always nivolumab’s fault?
Gelsomino, Francesco;Vitale, Giovanni;Ardizzoni, Andrea
2018
Abstract
Immune-related AEs (irAEs) affecting the biliary system on treatment with immune-oncology (I-O) agents, such PD-1/PD-L1 mAbs, are considered rare and their management remains unclear.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
